Lorajmine
From Wikipedia, the free encyclopedia
Clinical data | |
---|---|
ATC code | C01BA12 (WHO) |
Identifiers | |
|
|
CAS Number | 47562-08-3 |
PubChem (CID) | 76957773 |
ChemSpider | 16735878 |
UNII | F96VX65849 |
ChEMBL | CHEMBL2111031 |
ECHA InfoCard | 100.051.185 |
Chemical and physical data | |
Formula | C22H27ClN2O3 |
Molar mass | 402.914 g/mol |
3D model (Jmol) | Interactive image |
|
|
|
|
(verify) |
Lorajmine (17-monochloroacetylajmaline) is a drug that is a potent sodium channel blocker (more specifically, a class Ia antiarrhythmic agent) that was used for treating arrhythmia.[1][2] It is derived from ajmaline, an alkaloid from the roots of Rauwolfia serpentina, by synthetically adding a chloroacetate residue.
References[edit]
This drug article relating to the cardiovascular system is a stub. You can help Wikipedia by expanding it. |